Importantly, treatment with the HDAC8 inhibitor 22d, an ortho-Aryl-N-hydroxycinnamide, selectively induced apoptosis in mouse and human CBFβ-SMMHC expressing leukemia cells. This evidence concerns the gene MYH11 and leukemia.